Organization profile

Organisation profile

The TMU Research Center of Cancer Translational Medicine (RCCTM) is established through combining all cancer-related resources of TMU and its three affiliated hospitals. RCCTM is established with the goal of translating the research discoveries into state-of-the-art therapeutics for the prevention and treatment of cancer, as well as training future oncologists. We are committed to reduce the cancer burden through skilled, integrated and compassionate clinical care, and to eliminate the threat of cancer through research and education.

Fingerprint Dive into the research topics where RCCTM - AI & Smart Healthcare is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

Pneumonia Medicine & Life Sciences
Point-of-Care Systems Medicine & Life Sciences
Glomerular Filtration Rate Medicine & Life Sciences
Urinary Retention Medicine & Life Sciences
Muscular Diseases Medicine & Life Sciences
renal function Agriculture & Biology
pneumonia Agriculture & Biology
Hyperplasia Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2017 2019

  • 7 Citations
  • 1 h-Index
  • 4 Article

Microbial etiology of pneumonia in patients with decreased renal function

Chen, C. Y., Hsu, S. C., Hsieh, H. L., Suk, C. W., Hsu, Y. P., Sue, Y. M., Chen, T. H., Lin, F. Y., Shih, C. M., Chen, J. W., Lin, S. J., Huang, P. H. & Liu, C. T., May 1 2019, In : PLoS One. 14, 5, e0216367.

Research output: Contribution to journalArticle

Open Access
renal function
pneumonia
Lymphocytes
etiology
Pneumonia

Point of Care eGFR and the Prediction of Outcomes in Pneumonia

Suk, C. W., Hsu, S. C., Chen, C. Y., Hsieh, H. L., Kuo, H. T., Hsu, Y. P., Sue, Y. M., Chen, T. H., Lin, F. Y., Shih, C. M., Chen, J. W., Lin, S. J., Huang, P. H. & Liu, C. T., Dec 1 2019, In : Scientific Reports. 9, 1, 8478.

Research output: Contribution to journalArticle

Open Access
Point-of-Care Systems
Glomerular Filtration Rate
Pneumonia
Mortality
Intensive Care Units

Do 5α-reductase inhibitors prevent secondary benign prostate hyperplasia-related urinary retention?

Lu, C. F., Chen, C. Y., Lee, L. M., Lin, K. H., Lin, Y. W., Hsiao, C. H. & Wen, Y. C., Mar 1 2018, In : Urological Science. 29, 2, p. 86-90 5 p.

Research output: Contribution to journalArticle

Urinary Retention
Hyperplasia
Prostate
Oxidoreductases
International Classification of Diseases